SEC Form D · filed March 3, 2021
Asylia Therapeutics, Inc
Offering
$16.2M
Sold
$8.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
HOUSTON, TX
Type
—
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (6)
Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗